MORPHOSYS AG O.N. overview

MUNICH, GERMANY / ACCESSWIRE / August 27, 2024 / MorphoSys AG today announced that its shareholders approved all resolutions proposed by the company's Management Board and Supervisory Board at its 2024 Annual General Meeting. This included the transfer of MorphoSys' minority shareholders' shares to Novartis BidCo Germany AG (hereinafter referred to as "Novartis"), the company's majority shareholder, against a cash compensation of € 68.00 per share ("merger squeeze-out"). The merger squeeze-out...

EQS-News: MorphoSys AG / Key word(s): AGM/EGM Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting 27.08.2024 / 16:00 CET/CEST The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, Germany, August 27, 2024 Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting MorphoSys AG today announced that its shareholders approved all resolutions proposed by the company’s...

EQS-News: MorphoSys AG / Key word(s): Delisting MorphoSys Completes Voluntary Delisting from the Frankfurt Stock Exchange and Nasdaq Global Market 05.08.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, Germany, August 5, 2024 MorphoSys Completes Voluntary Delisting from the Frankfurt Stock Exchange and Nasdaq Global Market MorphoSys AG today announced that it has completed the voluntary delisting of its shares from the...

EQS-News: MorphoSys AG / Key word(s): Delisting MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market 12.07.2024 / 22:02 CET/CEST The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, Germany, July 12, 2024 MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its American...

EQS-Ad-hoc: MorphoSys AG / Key word(s): Squeeze Out Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00 12-Jul-2024 / 14:34 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 Key word(s): Squeeze Out...

EQS-News: MorphoSys AG / Key word(s): Squeeze Out MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders 20.06.2024 / 08:25 CET/CEST The issuer is solely responsible for the content of this announcement. Media Release Planegg/Munich, Germany, June 20, 2024 MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders MorphoSys AG (FSE: MOR; NASDAQ: MOR)...

PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to merge MorphoSys AG as transferring company into Novartis BidCo Germany AG. Novartis BidCo Germany AG proposed to enter negotiations with the MorphoSys AG Management Board on a merger agreement. In connection with the merger of MorphoSys AG into Novartis BidCo Germany AG, Novartis BidCo Germany AG...